Pacheco-Rosas O, Huelgas-Plaza AC, Miranda-Novales MG

Language: Spanish
References: 28
Page: 24-29
PDF size: 238.79 Kb.

ABSTRACT

Background: Neutropenia is a common chemotherapy-derived complication in cancer patients, in whom the prevalence of sepsis ranges from 12.9 % to 17.4 %, with a lethality rate of 16 %. The aim of this study was to determine the usefulness of serum lactate as a biomarker of severe sepsis in children with cancer, fever and neutropenia.
Methods: A phase II diagnostic test study was conducted. Lactate value was measured at admission. Neutropenia episodes were classified in three groups: I, with sepsis (patients with and without severe sepsis), II, without sepsis and III, neutropenic patients without fever (controls). Sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios were calculated. The gold standard was the clinical diagnosis of severe sepsis.
Results: A sample of 100 neutropenia episodes was collected: 16 were classified in group I, 73 in group II, and 11 in group III. Microbiological isolates were obtained in 11 samples, 4 from patients with severe sepsis and 6 from subjects without sepsis. A serum lactate level ≥ 2 mmol/L had a sensitivity of 81 %, 83 % specificity, a positive predictive value of 48 % and a negative predictive value of 95 %; the positive and negative likelihood ratios were 4.88 and 0.23, respectively. According to the ROC curve, the area under the curve was 0.851 (95 % CI = 0.725-0.977).
Conclusions: A serum lactate level ≥ 2 mmol/L is consistent with severe sepsis in children with cancer, fever and neutropenia who are hemodynamically stable and without hypoperfusion.

REFERENCES

1. Arnello LM, Quintana BJ, Barraza CP. Neutropenia febril en niños con cáncer en un centro asistencial en Santiago, Chile. Rev Chil Infectol. 2007;24(1):27-32.

2. Hugues WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34(6):730-51.

3. Mendes AV, Salponki R, Mendonca N. New guidelines for the clinical management of febrile neutropenia and sepsis en pediatric oncology patients. J Pediatr (Rio J). 2007;83(2):S54-63.

4. Santolaya ME, Rabagliati R, Ribart T, Paya E, Guzmán AM, Morales R, et al. Consenso: manejo racional del paciente con cáncer, neutropenia y fi ebre. Rev Chil Infectol. 2005;22(Supl 2):S79-113.

5. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Defi nitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2-8.

6. Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from American College of Critical Care Medicine. Crit Care Med. 2009;37(2):666-83.

7. Porras-García W, Ige-Afuso M, Ormeda-Villavicencio A. Depuración de lactato como indicador pronóstico de mortalidad en pacientes con sepsis severa y choque séptico. Rev Soc Peru Med Intern. 2007; 20(4):132-8.

8. Jones AE, Puskarich MA. Sepsis-induced tissue hypoperfusion. Crit Care Nurs Clin North Am. 2011; 23(1):115-25.

9. Okorie ON, Dellinger P. Lactate: Biomarker and potential therapeutic target. Crit Care Clin. 2011; 27(2):299-326.

10. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009;37(5):1670-7.

11. Nguyen HB, Rivers E, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637-42.

12. Green JP, Berger T, Nidhi G, Shapiro NI. Serum lactate is a better predictor of short term mortality when stratifi ed by C-reactive protein in adult emergency department patients hospitalized for a suspected infection. Ann Emer Med. 2011;57(3):291-5.

13. Del Portal DA, Shofer F, Mikkelsen ME, Dorsey PJ Jr, Gaieski DF, Goyal M, et al. Emergency department lactate is associated with mortality in older adults admitted with and without infections. Acad Emerg Med. 2010;17(3):260-8.

14. Borthwick HA, Brunt LK, Mitchem KL, Chaloner C. Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review. Ann Clin Biochem. 2012;49(4):391-4.

15. Husain FA, Martin MJ, Mullenix PS, Steele SR, Elliott DC. Serum lactate and base defi cit as predictors of mortality and morbidity. Am J Surg. 2003; 185(5):485- 91.

16. Jansen TC, Van Bommel J, Mulder PG, Rommes JH, Schieveld SJM, Bakker J. The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: A pilot study. Crit Care. 2008;12(6):1-7.

17. Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45(5):524-8.

18. Ramzi J, Mohamed Z, Yosr B, Karima K, Raihane B, Lamia A, et al. Predictive factors of septic shock and mortality in neutropenic patients. Hematology. 2007;12(6):543-48.

19. Mato AR, Luger SM, Heitjan DF, Mikkelsen ME, Olson E, Ujjani C, et al. Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically- stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biol Ther. 2010;9(8): 585-9.

20. Rondinelli PI, Ribeiro KC, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006;28(10): 665-70.

21. Koliski A, Cat I, Giralde DJ, Cat M. Blood lactate concentration as prognostic marker in critically ill children. J Pediatr (Rio J). 2005;81(4):287-92.

22. Jat KR, Jhamb U, Gupta VK. Serum lactate as the predictor of outcome in pediatric septic shock. Ind J Crit Care Med. 2011;15(2):102-7.

23. Chan FH, Carl D, Lyckholm LJ. Severe lactic acidosis in a patient with B-cell lymphoma: A case report and review of the literature. Case Rep Med. 2009. Disponible en http://www.hindawi.com/journals/crim/ 2009/534561/

24. De Groot R, Sprenger RA, Imholz AL, Gerding MN. Type B lactic acidosis in solid malignancies. Neth J Med. 2011;69(3):120-3.

25. Loja D, Vilca M, Postigo R, Torres A, Alvizuri J. Acidosis láctica y leucemia aguda. An Fac Med. 2004; 65(1):49-55.

26. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for de use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by de Infectious Diseases Society of America (IDSA). Clin Infect Dis. 2011;52(4):427-3.

27. Paganini H, Santolaya ME. Diagnóstico y tratamiento de la neutropenia febril en niños con cáncer. Consenso de la Sociedad Latinoamericana de Infectología Pediátrica. Rev Chil Infect. 2011;28(Supl 1):10-38.

28. Penagos PM, Villasís KMA, Miranda NMG, Tapia MA, Rivera MH, Bernáldez RR, et al. Utilidad de la proteína C reactiva para el diagnóstico de infección bacteriana en el paciente pediátrico con cáncer, fi ebre y neutropenia. Bol Med Hosp Infant Mex. 2012;69(5):376-83.